PODCAST

Healthcare Policy

ReachMD

science & medicine medicine

All Episodes

00:00:00

Physicians and Execution - Part 1

Healthcare Policy ·

2009/10/08

In this roundtable discussion, moderator Dr. Atul Gawande, surgeon and associate professor at Harvard Medical School and the Harvard School of Public Health, is joined by Deborah Denno, professor of law at Fordham University; Dr. Robert Truog, professor of medical ethics, anesthesiology, and pediatrics at Harvard Medical School; and Dr. David Waisel, associate professor of anesthesia at Harvard Medical School, in a conversation about lethal injection, the current protocol, possible

00:00:00

FDA Patient Safety News: Helping Healthcare...

Healthcare Policy ·

2009/10/01

Host: Charles Turck, PharmD, BCPS, BCCCP The FDA periodically releases documents in print and on its website that are geared toward healthcare professionals. New drugs, medical devices, safety notifications and product recalls: all are meant to help healthcare professionals protect patients. But channeling information through only the print medium may miss a large segment of an increasingly tech-savvy audience. How, then, does the FDA attract the more visual learners among us? The

00:00:00

The Importance of Immunizations for Diabetic Patients

Healthcare Policy ·

2009/09/28

Guest: Sarah Lorentz, PharmD Host: Candis Morello, PharmD, CDE Why are people living with diabetes more likely to die with flu and pneumonia? During flu epidemics, this risk is particularly high when additional risk factors present such as cardiovascular disease and kidney disease. Join guest host Dr. Candis Morello and her guest, pharmacist specializing in ambulatory care, Dr. Sarah Lorentz, as they discuss the reasons immunizations for patients with diabetes are so crucial.

00:00:00

Drug Delivery Systems in the Management of Diabetes

Healthcare Policy ·

2009/09/28

Host: Candis Morello, PharmD, CDE Guest: Brookie Best, PharmD New drug delivery technologies are changing one of the key therapeutic challenges of insulin delivery in the management of diabetes. Join guest host Dr. Candis Morello and her guest, Dr. Brookie Best, assistant clinical professor of pharmacy and pediatrics at University of California San Diego, as they discuss the emerging new technologies being developed in this space.

00:00:00

Sodium-Glucose Transporters: A New Class of Diabetes...

Healthcare Policy ·

2009/09/02

Host: Steven Edelman, MD Guest: Vivian Fonseca, MD, FRCP SGLT2 is responsible for glucose re-absorption in the kidney and decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive area for the treatment of diabetes. Join host Dr. Steven Edelman and his guest, professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss the new class of medications being investigated for the treatment of type-2 diabetes.

00:00:00

Do Incretins Play An Important Role In the...

Healthcare Policy ·

2009/09/02

Guest: John Buse, MD, PhD Host: Steven Edelman, MD Diabetes therapeutics such as glucose and weight control are major physiological functions of the new glucagon-like peptide-1 (GLP-1) agonists. But is there evidence to suggest that GLP-1 may also have some cardiovascular benefits? Join host Dr. Steven Edelman and Dr. John Buse, professor of medicine at the University of North Carolina at Chapel Hill School of Medicine,as they discuss the emerging cardiovascular actions of incretin

00:00:00

Race, Religion, Reproductive Choice, and Politics in...

Healthcare Policy ·

2009/08/17

Guest: Kenneth Edelin, MD Host: Martin Samuels, MD In 1974, one year after Roe v Wade, Dr. Kenneth C. Edelin, a young black doctor, was the chief resident in obstetrics at Boston City Hospital. Three months before completing his residency, Dr. Edelin was indicted for manslaughter after he surgically terminated a pregnancy. Convicted and sentenced to a one-year probation by a secret grand jury, before the decision was overturned by the Supreme Judicial Court of Massachusetts a year

00:00:00

The Motility of the Gut: What Do We Know?

Healthcare Policy ·

2009/08/04

Guest: Jack Grider, PhD Host: Mark DeLegge, MD What is the underlying mechanism of propulsion in the digestive system, and how is motility stimulated? How are some newer pharmacotherapies looking to target serotonin to treat conditions such as IBS and constipation? Dr. Jack Grider, professor in the department of medicine, division of gastroenterology at the Virginia Commonwealth University School of Medicine, talks about future pharmacotherapy directions that either suppress or

00:00:00

Point/Counterpoint: Treatment of IBS With Antibiotics

Healthcare Policy ·

2009/06/25

Guest: William Chey, MD Host: Mark DeLegge, MD Guest: Mark Pimentel, MD Irritable bowel syndrome, or IBS, affects a significant number of patients and can be challenging to treat. How might antibiotic therapy benefit IBS patients, and how is antibiotic therapy a unique option for treating IBS? Should physicians empirically treat IBS patients with antibiotics? Joining us to debate these questions are Dr. William Chey, professor in the department of internal medicine at the

00:00:00

New Developments in Incretins and SGLT Inhibitors

Healthcare Policy ·

2009/06/19

Guest: Robert Henry, MD Host: Steven Edelman, MD The physiological effects of glucagon-like peptide-1 (GLP-1) are exciting because of the potential clinical relevance in treating two of the major abnormalities that contribute to type 2 diabetes: impaired insulin secretion and excessive glucagon secretion.GLP-1also appears to have effects on gastric emptying and appetite suppression. Join host Dr. Steven Edelman and his guest Dr. Robert Henry,professor of medicine at the University

00:00:00

Therapeutic Monitoring of Vancomycin in Adult Patients

Healthcare Policy ·

2009/05/27

Guest: Michael Rybak, PharmD, MPH, PhD Host: Charles Turck, PharmD, BCPS, BCCCP Vancomycin has come full circle in recent years. First used as an alternative to penicillin nearly a half-century ago, it was surpassed by methicillin and other semisynthetic penicillins that were regarded as less toxic. Paradoxically, the subsequent rise of methicillin-resistant Staphylococcus aureus (MRSA) has reestablished vancomycin as the primary antibiotic treatment for MRSA infections. With this

00:00:00

Putting a Price on Quality When it Comes to...

Healthcare Policy ·

2009/05/16

Guest: Eric Elliott Host: Bruce Japsen What if prescription costs were tied to outcomes and how patients do on their prescriptions? It's already happening. Eric Elliott, president of CignaPharmacy Management, tells the Chicago Tribune's Bruce Japsen about new ways health benefits companies are working to provide more effective treatments.

00:00:00

How Close Are We to a Cardiac Polypill?

Healthcare Policy ·

2009/05/12

Host: Janet Wright, MD Guest: Salim Yusuf, DPhil, FRCPC Start with one part diuretic. Add one part ACE inhibitor, and sprinkle in one part beta blocker. Then add a dose of statins, and top it off with a portion of antiplatelets. Here we have the proposed recipe for a singular pill that some experts believe will eventually help us stick a fork in heart disease. Yet there are pharmacologic concerns and certainly clinical trials to pass before this drug comes to a practice near you

00:00:00

Contraceptive Hormones & CV Disease: Pursuing the Link

Healthcare Policy ·

2009/05/12

Host: Janet Wright, MD Guest: Noel Bairey Merz, MD Research tells us that more than 80 percent of American women have used hormonal contraception during their lives. Though evidence suggests hormonal contraception could offer anti-atheromatous effects, the verdict is far from in. Further, we have a lot to learn about the long-term risks for thrombosis, arrythmogenesis, vasomotion and beyond. As we study the potential links between contraceptive hormone use and cardiovascular

00:00:00

The FDA Drug-Approval Process for Allergy Products

Healthcare Policy ·

2009/05/01

Host: Todd Mahr, MD Guest: Warner Carr, MD What phases does the FDA use to approve a new medication, and why does this process take several years? Why must the active and excipient components of the medication, as well as the device, complete all of the testing phases? Dr. Warner Carr, allergist at Allergy and Asthma Associates in Mission Viejo, California, shares insight from his role as a new drug reviewer at the FDA. How do physicians play a vital role in the drug-approval

00:00:00

Linking Marijuana to Testicular Cancer

Healthcare Policy ·

2009/04/24

Host: Shira Johnson, MD Guest: Stephen Schwartz, PhD Approximately 8000 men are diagnosed every year with testicular cancer in the United States. A first-of-its-kind study looked at whether or not marijuana use increases the risk. Dr. Stephen Schwartz, one of the researchers on the study and professor of epidemiology at the University of Washington, discusses his findings with host Dr. Shira Johnson. The two discuss how the research was conducted, who took part, and what needs to

00:00:00

Pregnancy and Patients with PAH

Healthcare Policy ·

2009/04/08

Guest: Evelyn Hermes-DeSantis, PharmD Host: Charles Turck, PharmD, BCPS, BCCCP Pregnancy in patients with pulmonary arterial hypertension (PAH) is linked to several risks. Women of childbearing age are often encouraged to avoid pregnancy. But when pregnancy does occur, how can clinicians balance improvement of outcomes with considerations for the maternal and fetal health? Joining Dr. Charles Turck to discuss these issues and more is Dr.EvelynHermes-DeSantis,director of the Drug

00:00:00

The Continuing Evolution of Pharmacy Practice

Healthcare Policy ·

2009/03/26

Guest: William Zellmer, MPH Host: Charles Turck, PharmD, BCPS, BCCCP Every year, things change in healthcare. Looking retrospectively over the past 40 years in clinical pharmacy, we've seen nothing less than a revolution in the way we practice. Yet pharmacy practice, in many ways, remains dichotomous, when assessing our distributive and clinical duties. Host Dr. Charles Turck asks, Can we, and should we, find a way to reconcile these roles? And how do the changes of the past four

00:00:00

Anemia in the Long Term Care Setting

Healthcare Policy ·

2009/03/25

Guest: Charles Cefalu, MD MS Host: Eric Tangalos, MD What are the various types of anemia found in long-term care settings, and which types are the most common? What are some of the underlying causes of both chronic and acute anemia? Dr. Charles Cefalu, clinical professor and chief of the section of geriatric medicine at Louisiana State University Health Sciences Center, talks about how physicians can be alert to symptoms of anemia, which are often non-specific. What is the

00:00:00

A Therapeutic Vaccine for the Most Aggressive...

Healthcare Policy ·

2009/03/03

Guest: Keith Black, MD Host: Mark Nolan Hill, MD Despite our best efforts at surgery and chemotherapy for patients with glioblastoma, survival time is often far too limited. One novel weapon in our arsenal could be a vaccine that bolsters the immune system in the body's fight against these tumors. As we move forward with research toward a vaccine, what are the keys to boosting its efficacy? How much additional time could a vaccine buy for our glioblastoma patients? Host Dr. Mark

323 results

Healthcare Policy

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事